Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Safety of BNT162b2 mRNA COVID-19 Vaccine Batches: A Nationwide Cohort Study. — SciRadar

Back to results

Pharmacoepidemiology and drug safety

Safety of BNT162b2 mRNA COVID-19 Vaccine Batches: A Nationwide Cohort Study.

Max Schmeling, Vibeke Manniche, Peter Riis Hansen

Published: 202510.1002/pds.70270

No abstract available for this study.